Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, oncology equipment maker Varian Medical Systems (VAR) has earned a respected four-star ranking.
With that in mind, let's take a closer look at Varian and see what CAPS investors are saying about the stock right now.
Varian facts
|
Headquarters (founded) |
Palo Alto, Calif. (1948) |
|
Market Cap |
$7.8 billion |
|
Industry |
Health care equipment |
|
Trailing-12-Month Revenue |
$2.9 billion |
|
Management |
CEO Dow Wilson (since 2012) |
|
Return on Equity (average, past 3 years) |
28.4% |
|
Cash / Debt |
$807.3 million / $206.3 million |
|
Competitors |
Accuray |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 404 members who have rated Varian believe the stock will outperform the S&P 500 going forward.
Just yesterday, one of those Fools, dreamjob, succinctly summed up the bull case for our community: "Varian is sporting high returns on capital, and its earnings appear to be quality in nature (operating cash flow is keeping pace with net income). I like how sales, earnings, and book value are growing, and I think I'm getting this for a fair price at $71."
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
